Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18187923rdf:typepubmed:Citationlld:pubmed
pubmed-article:18187923lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C0040822lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C0016733lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C0020934lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C0597360lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C0392760lld:lifeskim
pubmed-article:18187923lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:18187923pubmed:issue1lld:pubmed
pubmed-article:18187923pubmed:dateCreated2008-1-23lld:pubmed
pubmed-article:18187923pubmed:abstractTextWe examined the influence of imipramine, a traditional tricyclic antidepressant, on the binding to serotonin (5-HT)(2) receptors and levels of 5-HT(2A)-receptor mRNA in the frontal cortex of rats treated with adrenocorticotropic hormone (ACTH). Chronic treatment with ACTH significantly increased the binding of [(3)H]-ketanserin to 5-HT(2) receptors and the expression of 5-HT(2A)-receptor mRNA in the frontal cortex. However, it did not alter the concentration of 5-HT or 5-hydroxyindole acetic acid. The effect of chronic ACTH treatment on 5-HT(2) receptor and 5-HT(2A)-receptor mRNA levels was not altered by the chronic administration of imipramine. Also, imipramine did not affect the hyperfunction of 5-HT(2A) receptors caused by chronic ACTH treatment. These findings suggest that chronic treatment with ACTH acts to increase 5-HT(2A)-receptor synthesis through increased gene transcription, without modulating presynaptic serotonergic neurotransmission.lld:pubmed
pubmed-article:18187923pubmed:languageenglld:pubmed
pubmed-article:18187923pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:citationSubsetIMlld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18187923pubmed:statusMEDLINElld:pubmed
pubmed-article:18187923pubmed:monthJanlld:pubmed
pubmed-article:18187923pubmed:issn1347-8613lld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:SendoToshiaki...lld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:KitamuraYoshi...lld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:GomitaYutakaYlld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:OuchidaMamoru...lld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:ShimizuKenjiKlld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:KawasakiHirom...lld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:ShibataKazuhi...lld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:KitagawaKouhe...lld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:KanzakiHirota...lld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:FujitaniYoshi...lld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:AkiyamaKozueKlld:pubmed
pubmed-article:18187923pubmed:authorpubmed-author:KimotoShizueSlld:pubmed
pubmed-article:18187923pubmed:issnTypePrintlld:pubmed
pubmed-article:18187923pubmed:volume106lld:pubmed
pubmed-article:18187923pubmed:ownerNLMlld:pubmed
pubmed-article:18187923pubmed:authorsCompleteYlld:pubmed
pubmed-article:18187923pubmed:pagination100-6lld:pubmed
pubmed-article:18187923pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:meshHeadingpubmed-meshheading:18187923...lld:pubmed
pubmed-article:18187923pubmed:year2008lld:pubmed
pubmed-article:18187923pubmed:articleTitleIncreased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex.lld:pubmed
pubmed-article:18187923pubmed:affiliationDepartment of Pharmaceutical Care and Health Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan. ykita@pheasant.pharm.okayama-u.ac.jplld:pubmed
pubmed-article:18187923pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18187923pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:29595entrezgene:pubmedpubmed-article:18187923lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18187923lld:entrezgene